Showing results (61-70 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|January 1, 1995
Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibilityK Kawajiri, J Watanabe, H Eguchi, et al.Pharmacogenetics|October 1, 1993
Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese malesN Rothman, R B Hayes, W Bi, et al.Pharmacogenetics|April 1, 1995
Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humansF Berthou, T Goasduff, D Lucas, et al.Pharmacogenetics|April 1, 1995
Cloning and stable expression of the human mitochondrial cytochrome P45011B1 cDNA in V79 Chinese hamster cells and their application for testing of potential inhibitorsK Denner, R Vogel, W Schmalix, et al.Pharmacogenetics|August 1, 1995
Pharmacogenetics of cocaine: a critical reviewA C Morse, V G Erwin, B C JonesPharmacogenetics|August 1, 1995
Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smokingE A Rosvold, K A McGlynn, E D Lustbader, et al.Pharmacogenetics|August 1, 1995
Comparison of substrate metabolism by wild type CYP2D6 protein and a variant containing methionine, not valine, at position 374C L Crespi, D T Steimel, B W Penman, et al.Pharmacogenetics|February 1, 1993
Predicting the cytochrome P450 mediated metabolism of xenobioticsK R Korzekwa, J P JonesPharmacogenetics|February 1, 1996
Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamsterR J Ferguson, M A Doll, T D Rustan, et al.Pharmacogenetics|August 1, 1996
Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2J T Buters, B K Tang, T Pineau, et al.Pageof 83